Improved outcomes for borderline resectable adenocarcinoma of the pancreas after neoadjuvant chemotherapy in a community cancer center

•Neoadjuvant chemotherapy for borderline resectable cancer leads to improved overall survival.•Outcomes in a community cancer center for borderline pancreatic cancer.•Morbidity and mortality for pancreaticoduodenectomy in borderline resectable pancreatic cancer.•Comparable resection rate and margin free resection rates in a community cancer center for borderline pancreatic cancer.